not losing weight on tirzepatide Can Help You Lose Weight? Why am I not losing

Bottom line (short) Tirzepatide is a novel dual GIP/GLP-1 receptor agonist that produces substantially greater average weight loss (in SURMOUNT-1 up to ~21% with 15 mg at 72 weeks) than placebo and larger weight and A1c reductions than some comparator GLP-1 therapies in trials

If you notice any of these changes, consult your healthcare provider before using it

For homogeneous binding, cells were incubated in binding buffer with a constant concentration of 125 I-GIP (30 pM, PerkinElmer) and increasing concentrations of unlabeled tirzepatide or peptide 20 (3.57 pM to 1 M) at RT for 3 h

This article shows you exactly how IV therapy works, which nutrients matter most, and practical ways to use this science-backed approach for optimal results